N/A
Completed N=60
Smartphone Intervention for Overdose and COVID-19
Source: ClinicalTrials.gov NCT05518461 ↗Enrolled (actual)
60
Serious AEs
0.0%
Results posted
Dec 2024
Primary outcomePrimary: Content Completion Rate Assessed as Number of Participants Who Completed at Least 6 of the 12 Weeks of the Intervention — 40 Participants
Summary
This study will examine if the use of a smartphone application called Thrive4Life Connect can help people who use drugs lower their risk of overdose and learn more about COVID-19 vaccines. 60 participants will be enrolled and can expect to be on study for up to 6 months.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Content Completion Rate Assessed as Number of Participants Who Completed at Least 6 of the 12 Weeks of the Intervention |
40 | — |
| SECONDARY Number of Days in the Past Month Endorsing Overdose Risk Behaviors |
2; 5; 14; 0; 0; 0 | — |
| SECONDARY Change in COVID-19 Vaccination Rates From Baseline |
30; 16; 17 | — |
Eligibility Criteria
Inclusion Criteria
- 18 years old or older
- Willing to attend in person study encounters at any of the following Vivent Health locations: Milwaukee, Appleton, and Eau Claire
- Used opioids to get high in the past 30 days
- Injected drugs at least 2 times in the past 7 days
- Express interest in reducing their overdose risk
Exclusion Criteria
- None in addition to the inclusion criteria
Data sourced from ClinicalTrials.gov (NCT05518461). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.